产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
R783697 | 2757083-53-5 | (3aR,8aS)-2-(6-二苯甲基吡啶-2-基)-8,8a-二氢四氢-3aH-茚并[1,2-d]恶唑, 95% (3aR,8aS)-2-(6-Benzhydrylpyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 95% |
C28H22N2O | |
S965988 | 1532531-18-2 | (3aS, 8aR)-2-(6-甲基吡啶-2-基)-3a, 8a-二氢-8H-茚并[1, 2-d]恶唑, 97%, 99%e.e. (3aS, 8aR)-2-(6-Methylpyridin-2-yl)-3a, 8a-dihydro-8H-indeno[1, 2-d]oxazole, 97%, 99%e.e. |
C16H14N2O | |
S746836 | 2412424-53-2 | (3aS,3a'S,8aR,8a'R)-2,2'-(1,3-双(3,5-二甲氧基苯基)丙烷-2,2-二基)双(3a,8a-二氢-8H-茚并[1,2-d]恶唑), 95% (3aS,3a'S,8aR,8a'R)-2,2'-(1,3-Bis(3,5-dimethoxyphenyl)propane-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole), 95% |
C39H38N2O6 | |
S782865 | 2757085-47-3 | (3aS,3a'S,8aR,8a'R)-2,2'-(1,3-双(4-(金刚烷-1-基)苯基)丙烷-2,2-二基)双(3a,8a-二氢-8H-茚并[1,2-d]恶唑), 97% (3aS,3a'S,8aR,8a'R)-2,2'-(1,3-Bis(4-(adamantan-1-yl)phenyl)propane-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole), 97% |
C55H58N2O2 | |
S749601 | 2412424-52-1 | (3aS,3a'S,8aR,8a'R)-2,2'-(1,3-双(4-溴苯基)丙烷-2,2-二基)双(3a,8a-二氢-8H-茚并[1,2-d]恶唑), 95% (3aS,3a'S,8aR,8a'R)-2,2'-(1,3-Bis(4-bromophenyl)propane-2,2-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole), 95% |
C35H28Br2N2O2 | |
S747673 | 2828438-16-8 | (3aS,8aR)-2-(1,10-菲咯啉-2-基)-3a,8a-二氢-8H-茚并[1,2-d]恶唑, 98% (3aS,8aR)-2-(1,10-Phenanthrolin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 98% |
C22H15N3O | |
S780640 | 2757082-48-5 | (3aS,8aR)-2-(1,8-萘啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑, 97% (3aS,8aR)-2-(1,8-Naphthyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole, 97% |
C18H13N3O | |
S783810 | 2757083-22-8 | (3aS,8aR)-2-(5-氯吡啶-2-基)-3a,8a-二氢-8H-茚并[1,2-d]恶唑, 97%, 99% e.e. (3aS,8aR)-2-(5-Chloropyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 99% e.e. |
C15H11ClN2O | |
S783520 | 2757083-29-5 | (3aS,8aR)-2-(5-溴吡啶-2-基)-3a,8a-二氢-8H-茚并[1,2-d]恶唑, 97%, 99% e.e. (3aS,8aR)-2-(5-Bromopyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 99% e.e. |
C15H11BrN2O | |
S784489 | 2757083-52-4 | (3aS,8aR)-2-(6-二苯甲基吡啶-2-基)-8,8a-二氢四氢-3aH-茚并[1,2-d]恶唑, ≥95% (3aS,8aR)-2-(6-Benzhydrylpyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, ≥95% |
C28H22N2O | |
S782607 | 2634687-79-7 | (3aS,8aR)-2-(6-苯基吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑, 97%, 99% e.e. (3aS,8aR)-2-(6-Phenylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole, 97%, 99% e.e. |
C21H16N2O | |
S782389 | 2757082-80-5 | (3aS,8aR)-2-(吡嗪-2-基)-3a,8a-二氢-8H-茚并[1,2-d]恶唑, 97% (3aS,8aR)-2-(Pyrazin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97% |
C14H11N3O | |
R735826 | 2387568-22-9 | (3R)-7-bromo-5-methyl-3-(tritylamino)-2,3-dihydro-1,5-benzoxazepin-4-one, 97% (3R)-7-bromo-5-methyl-3-(tritylamino)-2,3-dihydro-1,5-benzoxazepin-4-one, 97% |
C29H25N2O2Br | |
S781911 | 1330286-50-4 | (3S,7aR)-3-(三氯甲基)四氢-1H,3H-吡咯并[1,2-c]恶唑-1-酮, 98% (3S,7aR)-3-(Trichloromethyl)tetrahydro-1H,3H-pyrrolo[1,2-c]oxazol-1-one, 98% |
C7H8Cl3NO2 | |
T746158 | 1824624-51-2 | (4-(三氟甲基)恶唑-5-基)甲醇, 97% (4-(Trifluoromethyl)oxazol-5-yl)methanol, 97% |
C5H4F3NO2 | |
R982637 | 2757082-24-7 | (4R,4'R)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4-异丙基噁唑], 97% (4R,4'R)-2,2'-(2,3-Dihydro-1H-indene-2,2-diyl)bis(4-isopropyl-4,5-dihydrooxazole), 97% |
C21H28N2O2 | |
R746116 | 2828432-27-3 | (4R,4'R)-2,2'-(1,3-二苯基丙烷-2,2-二基)双(4-(叔丁基)-4,5-二氢恶唑), 98% (4R,4'R)-2,2'-(1,3-Diphenylpropane-2,2-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole), 98% |
C29H38N2O2 | |
R782915 | 2757085-41-7 | (4R,4'R)-2,2'-(1,3-双(4-(金刚烷-1-基)苯基)丙烷-2,2-二基)双(4-苯基-4,5-二氢恶唑), 97% (4R,4'R)-2,2'-(1,3-Bis(4-(adamantan-1-yl)phenyl)propane-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole), 97% |
C53H58N2O2 | |
R744931 | 1961269-71-5 | (4R,4'R)-2,2'-(丙烷-2,2-二基)双(4,5,5-三苯基-4,5-二氢恶唑), 97% (4R,4'R)-2,2'-(Propane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole), 97% |
C45H38N2O2 | |
R746117 | 2828432-10-4 | (4R,4'R)-2,2'-(戊烷-3,3-二基)双(4-甲基-4,5-二氢恶唑), 97% (4R,4'R)-2,2'-(Pentane-3,3-diyl)bis(4-methyl-4,5-dihydrooxazole), 97% |
C13H22N2O2 |